Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors
- PMID: 33415093
- PMCID: PMC7783321
- DOI: 10.3389/fpubh.2020.576964
Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors
Abstract
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2). TNBC constitutes about 15-30 percent of all diagnosed invasive breast cancer cases in the United States. African-American (AA) women have high prevalence of TNBC with worse clinical outcomes than European-American (EA) women. The contributing factors underlying racial disparities have been divided into two major categories based on whether they are related to lifestyle (non-biologic) or unrelated to lifestyle (biologic). Our objective in the present review article was to understand the potential interactions by which these risk factors intersect to drive the initiation and development of the disparities resulting in the aggressive TNBC subtypes in AA women more likely than in EA women. To reach our goal, we conducted literature searches using MEDLINE/PubMed to identify relevant articles published from 2005 to 2019 addressing breast cancer disparities primarily among AA and EA women in the United States. We found that disparities in TNBC may be attributed to racial differences in biological factors, such as tumor heterogeneity, population genetics, somatic genomic mutations, and increased expression of genes in AA breast tumors which have direct link to breast cancer. In addition, a large number of non-biologic factors, including socioeconomic deprivation adversities associated with poverty, social stress, unsafe neighborhoods, lack of healthcare access and pattern of reproductive factors, can promote comorbid diseases such as obesity and diabetes which may adversely contribute to the aggression of TNBC biology in AA women. Further, the biological risk factors directly linked to TNBC in AA women may potentially interact with non-biologic factors to promote a higher prevalence of TNBC, more aggressive biology, and poor survival. The relative contributions of the biologic and non-biologic factors and their potential interactions is essential to our understanding of disproportionately high burden and poor survival rates of AA women with TNBC.
Keywords: African-American women; body mass index; non-hispanic whites; obesity; racial disparities; socioeconomic status; triple negative breast cancer; waist-hip ratio.
Copyright © 2020 Prakash, Hossain, Danos, Lassak, Scribner and Miele.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.Breast Cancer Res Treat. 2019 May;175(1):247-259. doi: 10.1007/s10549-019-05156-5. Epub 2019 Feb 6. Breast Cancer Res Treat. 2019. PMID: 30725384 Free PMC article.
-
Racial Disparity in Quadruple Negative Breast Cancer: Aggressive Biology and Potential Therapeutic Targeting and Prevention.Cancers (Basel). 2022 Sep 16;14(18):4484. doi: 10.3390/cancers14184484. Cancers (Basel). 2022. PMID: 36139643 Free PMC article. Review.
-
Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants.Cancers (Basel). 2018 Dec 14;10(12):514. doi: 10.3390/cancers10120514. Cancers (Basel). 2018. PMID: 30558195 Free PMC article. Review.
-
Outcome of African-American compared to White-American patients with early-stage breast cancer, stratified by phenotype.Breast J. 2021 Jul;27(7):573-580. doi: 10.1111/tbj.14225. Epub 2021 Mar 18. Breast J. 2021. PMID: 33738890
-
Identifying Biomarkers Using Support Vector Machine to Understand the Racial Disparity in Triple-Negative Breast Cancer.J Comput Biol. 2023 Apr;30(4):502-517. doi: 10.1089/cmb.2022.0422. Epub 2023 Jan 30. J Comput Biol. 2023. PMID: 36716280 Free PMC article.
Cited by
-
Are there differences in outcomes by race among women with metastatic triple-negative breast cancer?Breast Cancer Res Treat. 2022 Nov;196(2):399-408. doi: 10.1007/s10549-022-06736-8. Epub 2022 Sep 24. Breast Cancer Res Treat. 2022. PMID: 36152139
-
Genomics and tumor microenvironment of breast mucoepidermoid carcinoma based on whole-exome and RNA sequencing.Diagn Pathol. 2024 Jan 19;19(1):15. doi: 10.1186/s13000-024-01439-8. Diagn Pathol. 2024. PMID: 38243319 Free PMC article.
-
Racial disparities in health insurance, triple-negative breast cancer diagnosis, tumor stage, treatment and survival in a large nationwide SEER cohort in the United States.Mol Clin Oncol. 2022 Apr;16(4):95. doi: 10.3892/mco.2022.2528. Epub 2022 Mar 2. Mol Clin Oncol. 2022. PMID: 35368847 Free PMC article.
-
Racial disparities in triple negative breast cancer: toward a causal architecture approach.Breast Cancer Res. 2022 Jun 1;24(1):37. doi: 10.1186/s13058-022-01533-z. Breast Cancer Res. 2022. PMID: 35650633 Free PMC article.
-
Clinical Profile of Triple-Negative Breast Cancer: A Hospital-Based Study.Cureus. 2024 Feb 1;16(2):e53373. doi: 10.7759/cureus.53373. eCollection 2024 Feb. Cureus. 2024. PMID: 38435145 Free PMC article.
References
-
- Spitale A, Mazzola P, Soldini D, Mazzucchelli L, Bordoni A. Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol. (2009) 20:628–35. 10.1093/annonc/mdn675 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous